Circulating Chlamydia pneumoniae DNA as a predictor of coronary artery disease

Journal of the American College of Cardiology

Volumn 34, Issue 5, 1999, Pages 1435-1439

  Wong, Yuk Ki ^a,b   Dawkins, Keith D ^b   Ward, Michael E ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; FIBRINOGEN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SEROLOGY; SEX DIFFERENCE; THROMBOCYTE; THROMBOCYTE COUNT;

AGED; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DNA, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOCYTES; POLYMERASE CHAIN REACTION; RISK FACTORS; SEX FACTORS;

EID: 0033231396     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00391-5     Document Type: Article

References (28)

1. Saikku P, Mattila K, Nieminen MS, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2:983-6.
2. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997;350:430-6.
3. Maass M, Bartels C, Engel PM, et al. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol 1998;31:827-32.
4. Muhlestein JB, Hammond EH, Carlquist JF, et al. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol 1996;27:1555-61.
5. Fong IW, Chiu B, Viira E, et al. Rabbit model for Chlamydia pneumoniae infection. J Clin Microbiol 1997;35:48-52.
6. Muhlestein JB, Anderson JL, Hammond EH, et al. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 1998;97:633-6.
7. Wong YK, Gallagher PJ, Ward ME. Chlamydia pneumomae and atherosclerosis. Heart 1999;81:232-8.
8. Gaydos CA, Summersgill JT, Sahney NN, et al. Replication of Chlamydia pneumomae in vitro in human macrophages, endothelial cells and aortic artery smooth muscle cells. Infect Immun 1996;64: 1614-20.
9. Wong YK, Thomas M, Tsang V, et al. The prevalence of Chlamydia pneumonme in atherosclerotic and nonatherosclerotic blood vessels of patients attending for redo and first time coronary artery bypass graft surgery. J Am Coll Cardiol 1999;33:152-6.
10. Cunningham AF, Johnston SL, Julious SA, et al. Chronic Chlamydia pneumonme infection and asthma exacerbations in children. Eur Resp J 1998;11:345-9.
11. Wong YK, Sueur JM, Fall CHD, et al. The species specificity of the microimmunofluorescence antibody test and comparisons with a time resolved fluoroscopic immunoassay for measuring IgG antibodies against Chlamydia pneumoniae. J Clin Pathol 1999;52:99-102.
12. Moazed TC, Kuo CC, Grayston JT, Campbell LA. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Dis 1998;177:1322-5.
13. Chirgwin K, Roblin PM, Gelling M, et al. Infection with Chlamydia pneumoniae m Brooklyn. J Infect Dis 1991;163:757-61.
14. Kuo CC, Shor A, Campbell LA, et al. Demonstration of Chlamydia pneumomae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993;167:841-9.
15. Campbell LA, O'Brien ER, Cappuccio AL, et al. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis 1995;172:585-8.
16. Davidson M, Kuo CC, Middaugh JP, et al. Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis. Circulation 1998;98:628-33.
17. Black CM. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev 1997;10:160.
18. Juvonen J, Juvonen T, Laurila A, et al. Can degenerative aortic valve stenosis be related to persistent Chlamydia pneumomae infection? Ann Intern Med 1998;128:741-4.
19. Patel P, Mendall MA, Carrington D, et al. Association of Helicobacter pylori ana Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. Brit Med J 1995;311:711-4.
20. Kark JD, Lemonen M, Paltiel O, Saikku P. Chlamydia pneumomae and acute myocardial infarction in Jerusalem. Int J Epidemiol 1997;26: 730-8.
21. Anderson JL, Carlquist JF, Muhlestem JB, et al. Evaluation of C-reactive protein, an inflammatory marker and infectious serology as risk factors for coronary artery disease and myocardial infarction. J Am Coll Cardiol 1998;32:35-41.
22. Nieto FJ, Folsom A, Sorlie P, Shahar E, Chambless LE, Szklo M. Chlamydia pneumomae infection and incident coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) Study [abstract]. Am J Epidemiol 1997;145:331.
23. Siscovick DS, Schwartz SM, Corey L, et al. Antibody to Chlamydia pneumomae, herpes simplex virus type 1, cytomegalovirus and incident myocardial infarction and coronary heart disease death: The Cardiovascular Health Study [abstract]. Circulation 1998;97:2.
24. Boman J, Soderberg S, ForsbergJ, et al. High prevalence of Chlamydia pneumomae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. J Infect Dis 1998;178:274-7.
25. Gupta S, Leatham EW, Carrington D, et al. Elevated Chlamydia pneumomae antibodies, cardiovascular events and azithromycin in male survivors of myocardial infarction. Circulation 1997;96:404-7.
26. Gurfinkel E, Bozovich G, Beck E, et al. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes-the final report of the ROXIS Study. Eur Heart J 1999;20: 121-7.
27. ACADEMIC (azithromycin in coronary artery disease: elimination of myocardial infection with Chlamydia). Clin Cardiol 1998;21:429-30.
28. Grayston JT. Antibiotic treatment of Chlamydia pneumomae for secondary prevention of cardiovascular events. Circulation 1998;97: 1669-70.